© Copyright Our Wall
The
DNA encoded library market is currently abuzz with activity; industry players
have forged several strategic alliances and received significant financial
support from investors. This can be attributed to the various benefits offered
by these platforms, such as cost effectiveness, high diversity, minimal false
positives, stability and rapid hit identification.
The financial opportunity within the DNA encoded library markethas been analyzed across the following
segments:
§ Application Area
§ Other Application Areas
§ Therapeutic Area
§ Oncological Disorders
§ Immunological Disorders
§ Neurological Disorders
§ Respiratory Disorders
§ Dermatological Disorders
§ Cardiovascular Disorders
§ Infectious Diseases
§ Other Therapeutic Areas
§ End-user
§ Other End-users
§ Type of Payment Model Employed
§ Key Geographical Regions
§ North America
§ Europe
§ Asia-Pacific
The
research also includes detailed profiles of key players (listed below) offering
DNA encoded libraryplatforms and services; each profile features a brief overview of the company,
its financial information (if available), details on platform and service
portfolio, recent developments and an informed future outlook.
§ AlphaMa
§ DICE
Therapeutics
§ DyNAbind
§ HitGen
§ NovAliX
§ Vipergen
§ WuXi
AppTec
§ X-Chem
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market
Landscape
5. Business
Model Analysis
6. Company
Competitiveness Analysis
7. Company
Profiles
8.
Partnerships and Collaborations
9. Global
Event Analysis
10. Patent
Analysis
11. Big
Pharma Initiatives
12. Case
Study: Companies / Organizations Supporting the Development of DNA Encoded
Libraries
13. Market
Forecast and Opportunity Analysis
14.
Concluding Remarks
15.
Executive Insights
16.
Appendix 1: Tabulated Data
17.
Appendix 2: List of Companies and Organizations
To
view more details on this report, click on the link:
https://www.rootsanalysis.com/reports/view_document/dna-encoded-libraries/288.html
Learn
from experts: do you know about these
emerging industry trends?
CAR-T Cell Therapies:
Addressing Key Unmet Needs Across Various Oncological Indications
Learn from our recently published
whitepaper: -
Next
Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the
pharma / biotech market research. Having worked with over 750 clients
worldwide, including Fortune 500 companies, start-ups, academia, venture
capitalists and strategic investors for more than a decade, we offer a highly
analytical / data-driven perspective to a network of over 450,000 senior
industry stakeholders looking for credible market insights.
Learn more about Roots
Analysis consulting services:
Roots Analysis Consulting - the
preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
The Wall